Gabon vs Syria: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Gabon
3.2%
in 2024
Syria
2.9%
in 2024
Gabon rank
3rd
Syria rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Gabon
- Syria
How they compare
Gabon currently reports 3.2% against 2.9% in Syria, a difference of 0.3%.
That makes Gabon's figure about 1.1 times Syria's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Gabon ahead.
Gabon ranks 3rd and Syria ranks 6th of 247 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.9% | 3.5% | 0.5% | Syria |
| 2020s | 3.1% | 3.4% | 0.3% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Gabon or Syria?
- Gabon, at 3.2% against 2.9% in Syria as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Gabon and Syria?
- 0.3%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Syria?
- 10 years are reported by both, from 2015 to 2024.
- How do Gabon and Syria rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Gabon ranks 3rd and Syria ranks 6th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.